At Grow Therapy, we recognized a hard truth: when Americans need mental health care most, the system too often fails them.
It asks people to navigate a maze of disconnected providers, insurance gaps, and long waitlists. So we set out to clear the pathway to effective care by breaking down those barriers.
Today, I’m excited to share a meaningful milestone in that journey.
Grow Therapy has raised a $150 million Series D, led by TCV and Growth Equity at Goldman Sachs Alternatives, who led our Series B and C respectively. New investors BCI and Menlo Ventures join existing investors Sequoia, SignalFire, and Transformation Capital.
This round is the direct result of what we’re seeing every day: health plans, employers, and health systems are choosing Grow as a partner to deliver high-quality, affordable mental healthcare to people who need it.
Read More – NODA AI Raises $25M in Series A Funding
